KMG Capital Partners

Circuit Clinical is an integrated research organization established to enhance participation in clinical research by connecting patients with trusted healthcare providers. Founded in 2015, the company has developed a network that includes over one million patients and focuses on the engagement of both physicians and participants. By utilizing HIPAA and FDA-compliant electronic medical record reviews, Circuit Clinical effectively identifies motivated participants. The organization offers research services that increase accessibility to clinical studies while guiding community physicians and their patients through each phase of the research process. This approach not only improves the quality of research sites but also prioritizes patient safety, ultimately fostering a more effective clinical research environment.

Surefire Medical, located in Westminster, Colorado, was established in 2009 to innovate in the interventional radiology sector. The company specializes in a unique infusion system that facilitates the precise delivery of embolic agents via its advanced catheter design. This system features an expandable tip that collapses during forward flow to preserve blood flow and expands against the vessel wall during reverse flow to minimize reflux. This innovative design aims to significantly reduce damage to healthy tissue, enhancing the effectiveness and safety of interventional procedures.

Bottlenose, Inc. is a business intelligence software company specializing in real-time data analysis to identify threats and opportunities for enterprises. Its primary product, Nerve Center, is a SaaS solution designed for enterprise analysts and strategists, enabling them to monitor various aspects of their business, including brand reputation, consumer insights, competitive intelligence, and crisis response. By automating processes such as machine learning, data mining, and predictive analytics, Bottlenose allows clients to focus on extracting valuable insights rather than managing data. The platform identifies patterns and trends within large volumes of rapidly changing information, facilitating comprehensive business awareness. Founded in 2010, Bottlenose is based in San Francisco, California, with additional offices in Los Angeles and New York City, and caters primarily to Fortune 100 companies.

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company based in Redwood City, California, that specializes in the development, manufacture, and marketing of biosimilar therapeutics. It primarily targets the oncology and inflammatory disease markets with its product offerings. The company's flagship product, UDENYCA, is a biosimilar to Neulasta, designed to stimulate the production of granulocytes to enhance the body’s infection-fighting capabilities. Coherus is also advancing several other biosimilar candidates, including those for Humira and Enbrel, which have completed Phase III clinical studies. Additionally, the company is working on biosimilars for other biologics, including ranibizumab and aflibercept, as well as a small-molecule drug for metabolic conditions. Coherus BioSciences was founded in 2010 and has established various license agreements to support its product development initiatives.

Wildflower Health, Inc. is a San Francisco-based company that provides smartphone-based health programs designed to help healthcare payers connect with families across the United States. Its flagship offering, Due Date Plus, is a maternity program that engages women in early pregnancy and facilitates connections with healthcare providers or care managers. Additionally, Wildflower Health offers GROW, a family health program that addresses the needs of mothers and pediatric health. The company delivers tailored health milestones for families based on age and gender, along with features such as client resource integrations, on-device messaging, appointment reminders, health risk assessments, and clinical program referrals. Founded in 2012, Wildflower Health aims to enhance user engagement and improve healthcare experiences through innovative technology and design.

FitBionic Inc. is a Boulder, Colorado-based company that specializes in designing and manufacturing prosthetic walking feet for individuals suffering from neuropathy, vascular disease, scarring, and fragile skin issues. Established in 2006 and previously known as Tensegrity Prosthetics Inc., FitBionic aims to provide whole-person care for amputees, promoting healthy and active lifestyles. The company's flagship product, the FitBionic Foot, has been shown to enhance walking efficiency compared to traditional carbon fiber prosthetics, while also potentially reducing pain and fall risks. FitBionic's research and development efforts have been supported by the National Institutes of Health, highlighting the company's commitment to creating high-quality and affordable prosthetic solutions that cater specifically to the needs of diabetics and other users. Through partnerships with centers of excellence, FitBionic seeks to ensure that its innovative products deliver comfort and functionality comparable to biological limbs.